A Study of Iguratimod in Combination With Tofacitinib in RA Patients

Clinical trial NCT06945666 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06945666
Sponsor: Jie Chang
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA

Start date: 2025-08-01
Primary completion: 2027-01-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.